RCKT
Price
$6.33
Change
+$0.18 (+2.93%)
Updated
Apr 17 closing price
Capitalization
674.97M
24 days until earnings call
RZLT
Price
$2.75
Change
+$0.11 (+4.17%)
Updated
Apr 17 closing price
Capitalization
166.47M
32 days until earnings call
Ad is loading...

RCKT vs RZLT

Header iconRCKT vs RZLT Comparison
Open Charts RCKT vs RZLTBanner chart's image
Rocket Pharmaceuticals
Price$6.33
Change+$0.18 (+2.93%)
Volume$2.2M
Capitalization674.97M
Rezolute
Price$2.75
Change+$0.11 (+4.17%)
Volume$907.23K
Capitalization166.47M
RCKT vs RZLT Comparison Chart
Loading...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCKT vs. RZLT commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCKT is a Hold and RZLT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (RCKT: $6.33 vs. RZLT: $2.75)
Brand notoriety: RCKT and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCKT: 89% vs. RZLT: 154%
Market capitalization -- RCKT: $674.97M vs. RZLT: $166.47M
RCKT [@Biotechnology] is valued at $674.97M. RZLT’s [@Biotechnology] market capitalization is $166.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCKT’s FA Score shows that 1 FA rating(s) are green whileRZLT’s FA Score has 1 green FA rating(s).

  • RCKT’s FA Score: 1 green, 4 red.
  • RZLT’s FA Score: 1 green, 4 red.
According to our system of comparison, both RCKT and RZLT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCKT’s TA Score shows that 5 TA indicator(s) are bullish while RZLT’s TA Score has 6 bullish TA indicator(s).

  • RCKT’s TA Score: 5 bullish, 3 bearish.
  • RZLT’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, RZLT is a better buy in the short-term than RCKT.

Price Growth

RCKT (@Biotechnology) experienced а +28.14% price change this week, while RZLT (@Biotechnology) price change was +11.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

RCKT is expected to report earnings on Aug 11, 2025.

RZLT is expected to report earnings on Sep 11, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($675M) has a higher market cap than RZLT($166M). RZLT YTD gains are higher at: -43.878 vs. RCKT (-49.642). RZLT has higher annual earnings (EBITDA): -73.3M vs. RCKT (-247.48M). RCKT has more cash in the bank: 372M vs. RZLT (96.5M). RZLT has less debt than RCKT: RZLT (1.93M) vs RCKT (25.5M). RCKT (0) and RZLT (0) have equivalent revenues.
RCKTRZLTRCKT / RZLT
Capitalization675M166M407%
EBITDA-247.48M-73.3M338%
Gain YTD-49.642-43.878113%
P/E RatioN/AN/A-
Revenue00-
Total Cash372M96.5M385%
Total Debt25.5M1.93M1,320%
FUNDAMENTALS RATINGS
RCKT vs RZLT: Fundamental Ratings
RCKT
RZLT
OUTLOOK RATING
1..100
1413
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9495
PRICE GROWTH RATING
1..100
9590
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (29) in the Biotechnology industry is in the same range as RZLT (31) in the null industry. This means that RCKT’s stock grew similarly to RZLT’s over the last 12 months.

RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RZLT (100) in the null industry. This means that RCKT’s stock grew similarly to RZLT’s over the last 12 months.

RCKT's SMR Rating (94) in the Biotechnology industry is in the same range as RZLT (95) in the null industry. This means that RCKT’s stock grew similarly to RZLT’s over the last 12 months.

RZLT's Price Growth Rating (90) in the null industry is in the same range as RCKT (95) in the Biotechnology industry. This means that RZLT’s stock grew similarly to RCKT’s over the last 12 months.

RZLT's P/E Growth Rating (100) in the null industry is in the same range as RCKT (100) in the Biotechnology industry. This means that RZLT’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCKTRZLT
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 1 day ago
88%
Declines
ODDS (%)
Bearish Trend 14 days ago
84%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLQVX18.23N/A
N/A
JPMorgan Large Cap Value I
PVIVX41.92N/A
N/A
Paradigm Micro-Cap
GRHAX12.50N/A
N/A
Goehring & Rozencwajg Resources Retail
CVMRX16.94N/A
N/A
Calvert Emerging Markets Equity R6
MGKAX11.47N/A
N/A
Morgan Stanley Global Permanence A

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with RGNX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
+2.93%
RGNX - RCKT
59%
Loosely correlated
-3.57%
DNLI - RCKT
59%
Loosely correlated
+1.51%
NTLA - RCKT
58%
Loosely correlated
+5.39%
ETNB - RCKT
57%
Loosely correlated
+2.89%
ACLX - RCKT
56%
Loosely correlated
+2.19%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with RLAY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
+4.17%
RLAY - RZLT
37%
Loosely correlated
+3.07%
ABEO - RZLT
31%
Poorly correlated
-0.21%
RCKT - RZLT
31%
Poorly correlated
+2.93%
COGT - RZLT
31%
Poorly correlated
+2.34%
RYTM - RZLT
30%
Poorly correlated
+0.65%
More